期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 756, 期 -, 页码 67-74出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2015.03.011
关键词
Functional proteomics; Hippocampus; ATP-ases; L-acetylcarnitine; Dementias; Depression
资金
- Italian Ministry of University and Research (M.I.U.R.)
- Sigma-Tau, Rome
- Premio Anna Licia Giovanetti
Synaptic energy state and mitochondrial dysfunction are crucial factors in many brain pathologies. L-acetylcarnitine, a natural derivative of carnitine, improves brain energy metabolism, and has been proposed for the Therapy of many neurological and psychiatric diseases. The effects of the drug on the maximum rate (V-max) of enzymatic activities related to hippocampal synaptic energy utilization were evaluated, in the perspective of its employment for Dementias and Depression Therapy. Two types of synaptic plasma membranes (SPM1 and SPM2) were isolated from the hippocampus of rats treated with L-acetylcarnitine (30 and 60 mg/kg i.p., 28 days, 5 days/week). Acetylcholinesterase (AChE); Na+, K+, Mg2+-ATP-ase; ouabain-insensitive Mg2+-ATP-ase; Na+, K+-ATP-ase; Ca2+, Mg2+-ATP-ase activities were evaluated. In control animals, enzymatic activities were differently expressed in SPM1, being the evaluated enzymatic activities higher in SPM2. Subchronic treatment with L-acetylcarnitine (i) did not modify AChE on both SPMs; (ii) increased Na+, K+, Mg2+-ATP-ase, ouabain-insensitive Mg2+-ATP-ase and Na+, K+-ATP-ase at the dose of 30 and 60 mg/kg on SPM1 and SPM2; (iii) increased Ca2+, Mg2+-ATP-ase activity on both SPMs at the close of 60 mg/kg. These results have been discussed considering the pathophysiology and treatment of Dementias and Depression because, although referred to normal healthy animals, they support the notion that L-acetylcarnitine may have positive effects in these pathologies. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据